Endothelial progenitor cells derived from Wharton's jelly of the umbilical cord reduces ischemia-induced hind limb injury in diabetic mice by inducing HIF-1α/IL-8 expression

Stem Cells and Development

Volumn 22, Issue 9, 2013, Pages 1408-1418

  Shen, Wen Ching ^a   Liang, Chan Jung ^a   Wu, Vin Cent ^b   Wang, Shu Huei ^a   Young, Guang Huar ^b   Lai, I Rue ^a   Chien, Chung Liang ^a   Wang, Seu Mei ^a   Wu, Kwan Dun ^b   Chen, Yuh Lien ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 8; SMALL INTERFERING RNA; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD FLOW; CAPILLARY DENSITY; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FEMORAL ARTERY; ISCHEMIA; LIMB INJURY; MALE; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; STREPTOZOCIN DIABETES; UMBILICAL CORD;

ANIMALS; APOPTOSIS; CELL HYPOXIA; CELL MOVEMENT; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; FEMORAL ARTERY; HINDLIMB; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERLEUKIN-8; ISCHEMIA; MALE; MICE; MICE, INBRED ICR; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; PERIPHERAL ARTERIAL DISEASE; REGIONAL BLOOD FLOW; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSCRIPTIONAL ACTIVATION; WHARTON JELLY;

MUS;

EID: 84876905906     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0445     Document Type: Article

References (39)

1. Miettinen H & V Salomaa. (1996). Diabetes & macrovascular disease. Coron Artery Dis 7:708-714.
2. Liu ZJ & OC Velazquez. (2008). Hyperoxia, endothelial progenitor cell mobilization & diabetic wound healing. Antioxid Redox Signal 10:1869-1882.
3. Georgescu A, N Alexandru, A Constantinescu, I Titorencu and D Popov. (2011). The promise of EPC-based therapies on vascular dysfunction in diabetes. Eur J Pharmacol 669: 1-6.
4. Shintani S, T Murohara, H Ikeda, T Ueno, K Sasaki, J Duan and T Imaizumi. (2001). Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 103:897-903.
5. Ballard VL & JM Edelberg. (2007). Stem cells & the regeneration of the aging cardiovascular system. Circ Res 100:1116-1127.
6. Wang SH, SJ Lin, YH Chen, FY Lin, JC Shih, CC Wu, HL Wu and YL Chen. (2009). Late outgrowth endothelial cells derived from Wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: involvement of pigment epithelium-derived factor. Arterioscler Thromb Vasc Biol 29:816-822.
7. Carmeliet P, Y Dor, JM Herbert, D Fukumura, K Brusselmans, M Dewerchin, M Neeman, F Bono, R Abramovitch, et al. (1998). Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation & tumour angiogenesis. Nature 394:485-490.
8. Schmidt A, K Brixius & W Bloch. (2007). Endothelial precursor cell migration during vasculogenesis. Circ Res 101:125-136.
9. Rey S, K Lee, CJ Wang, K Gupta, S Chen, A McMillan, N Bhise, A Levchenko & GL Semenza. (2009). Synergistic effect of HIF-1a gene therapy & HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia. Proc Natl Acad Sci U S A 106:20399-20404.
10. Rey S, W Luo, LA Shimoda & GL Semenza. (2011). Metabolic reprogramming by HIF-1 promotes the survival of bone marrow-derived angiogenic cells in ischemic tissue. Blood 117:4988-4998.
11. Pajusola K, J Künnapuu, S Vuorikoski, J Soronen, H André, T Pereira, P Korpisalo, S Ylä-Herttuala, L Poellinger & K Alitalo. (2005). Stabilized HIF-1a is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer. FASEB J 19:1365-1367.
12. Fang HY, R Hughes, C Murdoch, SB Coffelt, SK Biswas, AL Harris, RS Johnson, HZ Imityaz, MC Simon, et al. (2009). Hypoxia-inducible factors 1 & 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. Blood 114:844-859.
13. Li A, S Dubey, ML Varney, BJ Dave & RK Singh. (2003). IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production & regulated angiogenesis. J Immunol 170:3369-3376.
14. Westvik TS, TN Fitzgerald, A Muto, SP Maloney, JM Pimiento, TT Fancher, D Magri, HH Westvik, T Nishibe, OC Velazquez & A Dardik. (2009). Limb ischemia after iliac ligation in aged mice stimulates angiogenesis without arteriogenesis. J Vasc Surg 49:464-473.
15. Forsythe JA, BH Jiang, NV Iyer, F Agani, SW Leung, RD Koos & GL Semenza. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxiainducible factor 1. Mol Cell Biol 16:4604-4613.
16. Kim KS, V Rajagopal, C Gonsalves, C Johnson & VK Kalra. (2006). A novel role of hypoxia-inducible factor in cobalt chloride- & hypoxia-mediated expression of IL-8 chemokine in human endothelial cells. J Immunol 177:7211-7224.
17. Fadini GP, S Sartore, M Schiavon, M Albiero, I Baesso, A Cabrelle, C Agostini & A Avogaro. (2006). Diabetes impairs progenitor cell mobilisation after hindlimb ischaemiareperfusion injury in rats. Diabetologia 49:3075-3084.
18. Scheubel RJ, H Zorn, RE Silber, O Kuss, H Morawietz, J Holtz & A Simm. (2003). Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 42: 2073-2080.
19. Tse W & M Laughlin. (2005). Cord blood transplantation in adult patients. Cytotherapy 7:228-242.
20. Romanov YA, VA Svintsitskaya & VN Smirnov. (2003). Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 21:105-110.
21. Wang HS, SC Hung, ST Peng, CC Huang, HM Wei, YJ Guo, YS Fu, MC Lai & CC Chen. (2004). Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22:1330-1337.
22. Fu YS, YC Cheng, MY Lin, H Cheng, PM Chu, SC Chou, YH Shih, MH Ko & MS Sung. (2006). Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells 24:115-124.
23. Anzalone R, M Lo Iacono, S Corrao, F Magno, T Loria, F Cappello, G Zummo, F Farina & G La Rocca. (2010). New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity. Stem Cells Dev 19: 423-438.
24. Wu KH, B Zhou, SH Lu, B Feng, SG Yang, WT Du, DS Gu, ZC Han & YL Liu. (2007). In vitro & in vivo differentiation of human umbilical cord derived stem cells into endothelial cells. J Cell Biochem 100:608-616.
25. Yanagisawa-Miwa A, Y Uchida, F Nakamura, T Tomaru, H Kido, T Kamijo, T Sugimoto, K Kaji, M Utsuyama & C Kurashima. (1992). Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257:1401-1403.
26. Kawamoto A, HC Gwon, H Iwaguro, JI Yamaguchi, S Uchida, H Masuda, M Silver, H Ma, M Kearney, JM Isner and T Asahara. (2001). Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103:634-637.
27. Hsieh JY, YS Fu, SJ Chang, YH Tsuang & HW Wang. (2010). Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow & Wharton's jelly of umbilical cord. Stem Cells Dev 19:1895-1910.
28. Gnecchi M, Z Zhang, A Ni & VJ Dzau. (2008). Paracrine mechanisms in adult stem cell signaling & therapy. Circ Res 103:1204-1219.
29. Teodelinda M, C Michele, C Sebastiano, C Ranieri & G Chiara. (2011). Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-arteriogenesis in an ischemic model. Biomaterials 32: 3689-3699.
30. Kebir A, K Harhouri, B Guillet, JW Liu, A Foucault-Bertaud, E Lamy, E Kaspi, N Elganfoud, F Vely, et al. (2010). CD146 short isoform increases the proangiogenic potential of endothelial progenitor cells in vitro & in vivo. Circ Res 107:66-75.
31. Bosch-Marce M, H Okuyama, JB Wesley, K Sarkar, H Kimura, YV Liu, H Zhang, M Strazza, S Rey, et al. (2007). Effects of aging & hypoxia-inducible factor-1 activity on angiogenic cell mobilization & recovery of perfusion after limb ischemia. Circ Res 101:1310-1318.
32. Sarkar K, K Fox-Talbot, C Steenbergen, M Bosch-Marcé and GL Semenza. (2009). Adenoviral transfer of HIF-1a enhances vascular responses to critical limb ischemia in diabetic mice. Proc Natl Acad Sci U S A 106:18769-18774.
33. Bento CF & P Pereira. (2011). Regulation of hypoxiainducible factor 1 & the loss of the cellular response to hypoxia in diabetes. Diabetologia 54:1946-1956.
34. Botusan IR, VG Sunkari, O Savu, AI Catrina, J Grünler, S Lindberg, T Pereira, S Ylä-Herttuala, L Poellinger, K Brismar and SB Catrina. (2008). Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice. Proc Natl Acad Sci 105:19426-19431.
35. Yang Z, MW von Ballmoos, D Faessler, J Voelzmann, J Ortmann, N Diehm, W Kalka-Moll, I Baumgartner, S Di Santo & C Kalka. (2010). Paracrine factors secreted by endothelial progenitor cells prevent oxidative stress-induced apoptosis of mature endothelial cells. Atherosclerosis 211: 103-109.
36. Wang Y, A Sun, J Xue, C Feng, J Li & J Wu. (2009). Bone marrow derived stromal cells modified by adenovirusmediated HIF-1a double mutant protect cardiac myocytes against CoCl2-induced apoptosis. Toxicol In Vitro 23:1069-1075.
37. Koch AE, PJ Polverini, SL Kunkel, LA Harlow, LA DiPietro, VM Elner, SG Elner & RM Strieter. (1992). Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258:1798-1801.
38. Murdoch C, PN Monk & A Finn. (1999). Cxc chemokine receptor expression on human endothelial cells. Cytokine 11:704-712.
39. Frydelund-Larsen L, M Penkowa, T Akerstrom, A Zankari, S Nielsen & BK Pedersen. (2007). Exercise induces interleukin-8 receptor (CXCR2) expression in human skeletal muscle. Exp Physiol 92:233-240.